Parenteral Drugs (India) Ltd.
PDPL.NS
Price:
$2.9
Market Cap:
$101.08M
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-08-19
Stock Exchange
NSE
Ticker
PDPL.NS
PE Ratio
[-0.11]
ROE
[10.13%]
Current Ratio
[0.06]
Dividend Yield
[0%]
Enterprise Value
[1.17B]
Dividend History
The ROE as of November 2025 (TTM) for Parenteral Drugs (India) Ltd. (PDPL.NS) is 10.13%
According to Parenteral Drugs (India) Ltd.’s latest financial reports and current stock price. The company's current ROE is 10.13%. This represents a change of 2.43% compared to the average of 0.40% of the last 4 quarters.
Parenteral Drugs (India) Ltd. (PDPL.NS) Historical ROE (quarterly & annually)
How has PDPL.NS ROE performed in the past?
The mean historical ROE of Parenteral Drugs (India) Ltd. over the last ten years is -4.23%. The current 10.13% ROE has changed -339.73% with respect to the historical average. Over the past ten years (40 quarters), PDPL.NS's ROE was at its highest in in the September 2017 quarter at 37.22%. The ROE was at its lowest in in the March 2014 quarter at -30.87%.
Average
-4.23%
Median
-6.53%
Minimum
-54.79%
Maximum
87.18%
Parenteral Drugs (India) Ltd. (PDPL.NS) ROE by Quarter and Year
Discovering the peaks and valleys of Parenteral Drugs (India) Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 186.41%
Maximum Annual ROE = 87.18%
Minimum Annual Increase = -259.12%
Minimum Annual ROE = -54.79%
| Year | ROE | Change |
|---|---|---|
| 2022 | 9.27% | -48.01% |
| 2021 | 17.82% | -12.30% |
| 2020 | 20.32% | -38.59% |
| 2019 | 33.09% | -62.04% |
| 2018 | 87.18% | -259.12% |
| 2017 | -54.79% | 52.95% |
| 2016 | -35.82% | -32.71% |
| 2015 | -53.23% | 138.45% |
| 2014 | -22.33% | -49.03% |
| 2013 | -43.80% | 186.41% |
Parenteral Drugs (India) Ltd. (PDPL.NS) Average ROE
How has PDPL.NS ROE performed in the past?
The current ROE of Parenteral Drugs (India) Ltd. (PDPL.NS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
15.80%
5-year avg
33.54%
10-year avg
-4.23%
Parenteral Drugs (India) Ltd. (PDPL.NS) ROE vs. Peers
How is PDPL.NS’s ROE compared to its peers?
Parenteral Drugs (India) Ltd.’s ROE is less than Ganga Pharmaceuticals Limited (1.11%), greater than Ortin Laboratories Limited (-117.48%), less than Fabino Enterprises Ltd (1.46%), less than Bafna Pharmaceuticals Limited (16.75%), less than Vivimed Labs Ltd. (100.22%),
| Company | ROE | Market cap |
|---|---|---|
| 1.11% | $69.05M | |
| -117.48% | $165.31M | |
| 1.46% | $48.30M | |
| 16.75% | $242.50M | |
| 100.22% | $410.42M |
Build a custom stock screener for Parenteral Drugs (India) Ltd. (PDPL.NS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Parenteral Drugs (India) Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Parenteral Drugs (India) Ltd. (PDPL.NS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Parenteral Drugs (India) Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Parenteral Drugs (India) Ltd.'s ROE?
How is the ROE calculated for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the highest ROE for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the 3-year average ROE for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the 5-year average ROE for Parenteral Drugs (India) Ltd. (PDPL.NS)?
How does the current ROE for Parenteral Drugs (India) Ltd. (PDPL.NS) compare to its historical average?